PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2022-06-02 (3)

Date Title Company
02-Jun-2022 Accutar Biotechnology Announces Fast Track Designation Granted by FDA to AC0176 for the Treatment of Metastatic Castration-Resistant Prostate Cancer Businesswire